PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS IN PATIENTS WITH CANCER

Abstract

Cancer is one of the most significant risk factors for venous thromboembolic events (VTEE). The article discusses the contemporary landscape of drug thromboprophylaxis in various groups of patients with cancer.

Keywords

• oncological diseases
• venous thromboembolic events
• drug prophylaxis